Human Gene CPT2 (ENST00000371486.4_4) from GENCODE V47lift37
  Description: carnitine palmitoyltransferase 2, transcript variant 1 (from RefSeq NM_000098.3)
Gencode Transcript: ENST00000371486.4_4
Gencode Gene: ENSG00000157184.7_8
Transcript (Including UTRs)
   Position: hg19 chr1:53,662,496-53,679,869 Size: 17,374 Total Exon Count: 5 Strand: +
Coding Region
   Position: hg19 chr1:53,662,616-53,679,267 Size: 16,652 Coding Exon Count: 5 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviewsModel Information
Methods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:53,662,496-53,679,869)mRNA (may differ from genome)Protein (658 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: CPT2_HUMAN
DESCRIPTION: RecName: Full=Carnitine O-palmitoyltransferase 2, mitochondrial; EC=2.3.1.21; AltName: Full=Carnitine palmitoyltransferase II; Short=CPT II; Flags: Precursor;
CATALYTIC ACTIVITY: Palmitoyl-CoA + L-carnitine = CoA + L- palmitoylcarnitine.
PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
SUBCELLULAR LOCATION: Mitochondrion inner membrane; Peripheral membrane protein; Matrix side.
DISEASE: Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110]; also known as CPT-II deficiency or CPT2 deficiency. CPT2D is an autosomal recessive disorder characterized by recurrent myoglobinuria, episodes of muscle pain, stiffness, and rhabdomyolysis. These symptoms are triggered by prolonged exercise, fasting or viral infection and patients are usually young adults. In addition to this classical, late-onset, muscular type, a hepatic or hepatocardiomuscular form has been reported in infants. Clinical pictures in these children or neonates include hypoketotic hypoglycemia, liver dysfunction, cardiomyopathy and sudden death.
DISEASE: Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency infantile (CPT2DI) [MIM:600649]. A disorder of mitochondrial long-chain fatty acid oxidation characterized by hepatic or hepato-cardio-muscular manifestations with onset in infancy. Clinical features include hypoketotic hypoglycemia, lethargy, seizures, hepatomegaly, liver dysfunction, cardiomegaly and dilated cardiomyopathy.
DISEASE: Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency lethal neonatal (CPT2D-LN) [MIM:608836]; also known as lethal neonatal CPT-II deficiency. It is a lethal neonatal form of CPT2D. This rarely presentation is antenatal with cerebral periventricular cysts and cystic dysplastic kidneys. The clinical variability of the disease is likely attributed to the variable residual enzymatic activity.
DISEASE: Defects in CPT2 are a cause of susceptibility to encephalopathy acute infection-induced type 4 (IIAE4) [MIM:614212]. A severe neurologic complication of an infection. It manifests within days in otherwise healthy children after common viral infections, without evidence of viral infection of the brain or inflammatory cell infiltration. In affected children, high- grade fever is accompanied within 12 to 48 hours by febrile convulsions, often leading to coma, multiple-organ failure, brain edema, and high morbidity and mortality. The infections are usually viral, particularly influenza, although other viruses and even mycoplasma have been found to cause the disorder. Note=Polymorphic variants in CPT2 can confer susceptibility to infection-induced encepalopathy. These variants do not cause classical carnitine palmitoyltransferase 2 deficiency, and patients harboring any of them are asymptomatic most of the time. However, they are prone to viral infection (high fever)-related encephalopathy (PubMed:21697855).
SIMILARITY: Belongs to the carnitine/choline acetyltransferase family.
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/CPT2";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: CPT2
Diseases sorted by gene-association score: cpt ii deficiency, myopathic, stress-induced* (1550), cpt ii deficiency, infantile* (1550), cpt ii deficiency, lethal neonatal* (1250), encephalopathy, acute, infection-induced, 4* (594), carnitine palmitoyltransferase ii deficiency* (541), infection-induced acute encephalopathy 4, susceptibility* (100), myoglobinuria (21), dandy-walker syndrome (16), myoglobinuria recurrent (15), mcardle disease (11), carnitine-acylcarnitine translocase deficiency (11), fatty acid oxidation disorders (9), glycogen storage disease iv (9), carnitine deficiency, systemic primary (7), malignant hyperthermia (7), richter's syndrome (6), vlcad deficiency (6), glutaric acidemia iic (5), myopathy (4), dilated cardiomyopathy (2), cardiomyopathy (2)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 14.37 RPKM in Liver
Total median expression: 272.58 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -56.00120-0.467 Picture PostScript Text
3' UTR -195.80602-0.325 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR000542 - Carn_acyl_trans

Pfam Domains:
PF00755 - Choline/Carnitine o-acyltransferase

SCOP Domains:
52777 - CoA-dependent acyltransferases

ModBase Predicted Comparative 3D Structure on P23786
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologGenome BrowserGenome Browser
Gene DetailsGene Details Gene DetailsGene DetailsGene Details
Gene SorterGene Sorter Gene SorterGene SorterGene Sorter
 RGDEnsembl WormBaseSGD
    Protein SequenceProtein Sequence
    AlignmentAlignment

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0004095 carnitine O-palmitoyltransferase activity
GO:0016740 transferase activity
GO:0016746 transferase activity, transferring acyl groups

Biological Process:
GO:0006629 lipid metabolic process
GO:0006631 fatty acid metabolic process
GO:0006635 fatty acid beta-oxidation
GO:0006853 carnitine shuttle
GO:0019216 regulation of lipid metabolic process

Cellular Component:
GO:0005654 nucleoplasm
GO:0005730 nucleolus
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0016020 membrane


-  Descriptions from all associated GenBank mRNAs
  U09648 - Human carnitine palmitoyltransferase II precursor (CPT1) mRNA, complete cds.
HM005553 - Homo sapiens clone HTL-S-13 testicular secretory protein Li 13 mRNA, complete cds.
BC002445 - Homo sapiens carnitine palmitoyltransferase 2, mRNA (cDNA clone MGC:1771 IMAGE:3346025), complete cds.
BC005172 - Homo sapiens carnitine palmitoyltransferase 2, mRNA (cDNA clone MGC:4851 IMAGE:3605012), complete cds.
AK312687 - Homo sapiens cDNA, FLJ93082, Homo sapiens carnitine palmitoyltransferase II (CPT2), nuclear geneencoding mitochondrial protein, mRNA.
M58581 - Human carnitine palmitoyltransferase (CPT1) mRNA, complete cds.
AK223052 - Homo sapiens mRNA for Carnitine O-palmitoyltransferase II, mitochondrial precursor variant, clone: KAT00361.
DQ577918 - Homo sapiens piRNA piR-46030, complete sequence.
DQ573824 - Homo sapiens piRNA piR-41936, complete sequence.
JD347908 - Sequence 328932 from Patent EP1572962.
JD131972 - Sequence 112996 from Patent EP1572962.
JD023510 - Sequence 4534 from Patent EP1572962.
JD510325 - Sequence 491349 from Patent EP1572962.
JD060648 - Sequence 41672 from Patent EP1572962.
JD425153 - Sequence 406177 from Patent EP1572962.
JD531422 - Sequence 512446 from Patent EP1572962.
JD175597 - Sequence 156621 from Patent EP1572962.
JD331770 - Sequence 312794 from Patent EP1572962.
JD182502 - Sequence 163526 from Patent EP1572962.
JD350974 - Sequence 331998 from Patent EP1572962.
JD512524 - Sequence 493548 from Patent EP1572962.
JD097449 - Sequence 78473 from Patent EP1572962.
JD050855 - Sequence 31879 from Patent EP1572962.
JD364624 - Sequence 345648 from Patent EP1572962.
JD366922 - Sequence 347946 from Patent EP1572962.
JD520580 - Sequence 501604 from Patent EP1572962.
JD217236 - Sequence 198260 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  BioCyc Knowledge Library
PWY-6111 - mitochondrial L-carnitine shuttle

BioCarta from NCI Cancer Genome Anatomy Project
h_cptPathway - Mitochondrial Carnitine Palmitoyltransferase (CPT) System

Reactome (by CSHL, EBI, and GO)

Protein P23786 (Reactome details) participates in the following event(s):

R-HSA-200410 palmitoylcarnitine + CoASH => palmitoyl-CoA + carnitine
R-HSA-1989781 PPARA activates gene expression
R-HSA-400206 Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
R-HSA-200425 Import of palmitoyl-CoA into the mitochondrial matrix
R-HSA-556833 Metabolism of lipids
R-HSA-8978868 Fatty acid metabolism
R-HSA-1430728 Metabolism

-  Other Names for This Gene
  Alternate Gene Symbols: B2R6S0, CPT1, CPT2 , CPT2_HUMAN, ENST00000371486.1, ENST00000371486.2, ENST00000371486.3, NM_000098, P23786, Q5SW68, Q9BQ26, uc318jem.1, uc318jem.2
UCSC ID: ENST00000371486.4_4
RefSeq Accession: NM_000098.3
Protein: P23786 (aka CPT2_HUMAN)

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene CPT2:
cpt2 (Carnitine Palmitoyltransferase II Deficiency)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.